Rudolf Tauber

Title: Rudolf Tauber: Innovator in Recombinant Glycoproteins

Introduction

Rudolf Tauber is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of recombinant glycoproteins. His work has implications for various medical applications, especially in the human circulatory system.

Latest Patents

Rudolf Tauber holds a patent for "Recombinant glycoproteins, method for the production thereof, medicaments containing said glycoproteins and use thereof." This invention relates to novel recombinant glycoproteins that serve as messenger substances, signaling substances, promoters, stimulators, and initiators in the animal, particularly human, circulatory system. The patent details a method for producing these glycoproteins, as well as pharmaceutical agents that contain them. Specifically, it focuses on recombinant human glycoproteins, including differentiation factors, growth factors, thrombolytic agents, thromboprophylactic agents, coagulation factors, interferons, and interleukins.

Career Highlights

Throughout his career, Rudolf Tauber has demonstrated a commitment to advancing medical science through innovative research. His patent reflects a deep understanding of biochemistry and its applications in medicine.

Collaborations

Rudolf has collaborated with notable colleagues such as Werner Reutter and Rüdiger Horstkorte, contributing to the advancement of their shared research interests.

Conclusion

Rudolf Tauber's work in recombinant glycoproteins showcases his innovative spirit and dedication to improving human health. His contributions are vital to the ongoing development of effective medical treatments.